GHRS included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding GHRS
7 latest ETF portfolios currently report this security. This page shows rows 1–7 of 7.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| PSIL | AdvisorShares Psychedelics ETF | 4.654587% | Present before retained history; addition date unavailable | 2026-03-31 |
| BBC | Virtus Biotech Clinical Trials Etf | 1.1644% | 2025-07-31 | 2026-04-30 |
| EIRL | iShares MSCI Ireland ETF | 0.810353% | 2026-02-28 | 2026-02-28 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.067758% | 2026-02-28 | 2026-02-28 |
| IBB | iShares Biotechnology ETF | 0.057842% | 2026-03-31 | 2026-03-31 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 0.046375% | 2026-02-28 | 2026-02-28 |
| GWX | State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 0.019143% | 2026-03-31 | 2026-03-31 |